Bibliographic Details
Title: |
MiR-31-5p alleviates septic cardiomyopathy by targeting BAP1 to inhibit SLC7A11 deubiquitination and ferroptosis |
Authors: |
Yafeng Liu, Niandan Hu, Bo Ai, Hao Xia, Wenqiang Li |
Source: |
BMC Cardiovascular Disorders, Vol 24, Iss 1, Pp 1-13 (2024) |
Publisher Information: |
BMC, 2024. |
Publication Year: |
2024 |
Collection: |
LCC:Diseases of the circulatory (Cardiovascular) system |
Subject Terms: |
Septic cardiomyopathy, miR-31-5p, BAP1, Ferroptosis, Deubiquitination., Diseases of the circulatory (Cardiovascular) system, RC666-701 |
More Details: |
Abstract Septic cardiomyopathy is one of the most severe and common complications in patients with sepsis and poses a great threat to their prognosis. However, the potential mechanisms and effective therapeutic drugs need to be explored. The control of cardiac cell death by miRNAs has emerged as a prominent area of scientific interest in the diagnosis and treatment of heart disorders in recent times. In the present investigation, we discovered that overexpression of miR-31-5p prevented LPS-induced damage to H9C2 cells and that miR-31-5p could inhibit BAP1 production by binding to its 3’-UTR. BRCA1-Associated Protein 1 (BAP1) is a ubiquitin carboxy-terminal hydrolase. BAP1 upregulation blocked effect of miR-31-5p on H9C2 cell injury. Moreover, BAP1 inhibited the expression of solute carrier family 7 member 11 (SLC7A11) by deubiquitinating histone 2 A (H2Aub) on the promoter of SLC7A11. Furthermore, overexpression of miR-31-5p and downregulation of BAP1 inhibited SLC7A11 mediated ferroptosis. In addition, the downregulation of SLC7A11 reversed the inhibitory effect of miR-31-5p on the expression of myocardial injury and inflammatory factors, and cell apoptosis was reversed. In conclusion, these results indicate that miR-31-5p alleviates malignant development of LPS-induced H9C2 cell injury by targeting BAP1 and regulating SLC7A11 deubiquitination-mediated ferroptosis, which confirmed the protective effect of miR-31-5p on H9C2 cell injury and revealed potential mechanisms that may provide new targets for treatment of septic cardiomyopathy. |
Document Type: |
article |
File Description: |
electronic resource |
Language: |
English |
ISSN: |
1471-2261 |
Relation: |
https://doaj.org/toc/1471-2261 |
DOI: |
10.1186/s12872-024-03954-4 |
Access URL: |
https://doaj.org/article/de38a1da3c0c41c68f89994996fa8992 |
Accession Number: |
edsdoj.38a1da3c0c41c68f89994996fa8992 |
Database: |
Directory of Open Access Journals |